Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Contribution of the Cerebellum to Predictive Motor Control and Its Evaluation in Ataxic Patients.

Kakei S, Lee J, Mitoma H, Tanaka H, Manto M, Hampe CS.

Front Hum Neurosci. 2019 Jun 26;13:216. doi: 10.3389/fnhum.2019.00216. eCollection 2019.

2.

Response to Comment on Mulukutla et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes. Diabetes Care 2018;41:2637-2640.

Mulukutla SN, Acevedo-Calado M, Hampe CS, Pietropaolo M, Balasubramanyam A.

Diabetes Care. 2019 May;42(5):e82-e83. doi: 10.2337/dci19-0007. No abstract available.

PMID:
31010950
3.

Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?

Manto M, Mitoma H, Hampe CS.

Cerebellum. 2019 Apr;18(2):153-156. doi: 10.1007/s12311-018-0986-6.

4.

Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes.

Mulukutla SN, Acevedo-Calado M, Hampe CS, Pietropaolo M, Balasubramanyam A.

Diabetes Care. 2018 Dec;41(12):2637-2640. doi: 10.2337/dc18-0613. Epub 2018 Oct 16.

PMID:
30327357
5.

Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform: relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus.

Hampe CS, Radtke JR, Wester A, Carlsson A, Cedervall E, Jönsson B, Ivarsson SA, Elding Larsson H, Larsson K, Lindberg B, Neiderud J, Rolandsson O, Lernmark Å.

Diabet Med. 2018 Sep 27. doi: 10.1111/dme.13827. [Epub ahead of print]

PMID:
30264481
6.

Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.

Mitoma H, Manto M, Hampe CS.

Curr Neuropharmacol. 2019;17(1):33-58. doi: 10.2174/1570159X16666180917105033. Review.

7.

Endocrine disorders and the cerebellum: from neurodevelopmental injury to late-onset ataxia.

Manto M, Hampe CS.

Handb Clin Neurol. 2018;155:353-368. doi: 10.1016/B978-0-444-64189-2.00023-8. Review.

PMID:
29891071
8.

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Liimatainen S, Honnorat J, Pittock SJ, McKeon A, Manto M, Radtke JR; T1D Exchange Biobank, Hampe CS.

Orphanet J Rare Dis. 2018 Apr 10;13(1):55. doi: 10.1186/s13023-018-0787-5.

9.

Arginine Metabolism Is Altered in Adults with A-β + Ketosis-Prone Diabetes.

Mulukutla SN, Hsu JW, Gaba R, Bohren KM, Guthikonda A, Iyer D, Ajami NJ, Petrosino JF, Hampe CS, Ram N, Jahoor F, Balasubramanyam A.

J Nutr. 2018 Feb 1;148(2):185-193. doi: 10.1093/jn/nxx032.

10.

Time Is Cerebellum.

Mitoma H, Manto M, Hampe CS.

Cerebellum. 2018 Aug;17(4):387-391. doi: 10.1007/s12311-018-0925-6.

11.

Assessment of disturbed glucose metabolism and surrogate measures of insulin sensitivity in obese children and adolescents.

Roth CL, Elfers C, Hampe CS.

Nutr Diabetes. 2017 Dec 14;7(12):301. doi: 10.1038/s41387-017-0004-y.

12.

Identification of insulin-sensitizing molecules acting by disrupting the interaction between the Insulin Receptor and Grb14.

Gondoin A, Hampe C, Eudes R, Fayolle C, Pierre-Eugène C, Miteva M, Villoutreix BO, Charnay-Pouget F, Aitken DJ, Issad T, Burnol AF.

Sci Rep. 2017 Dec 4;7(1):16901. doi: 10.1038/s41598-017-17122-6.

13.

Elevated unmethylated and methylated insulin DNA are unique markers of A+β+ ketosis prone diabetes.

Mulukutla SN, Tersey SA, Hampe CS, Mirmira RG, Balasubramanyam A.

J Diabetes Complications. 2018 Feb;32(2):193-195. doi: 10.1016/j.jdiacomp.2017.10.013. Epub 2017 Oct 31.

14.

Effect of dietary palmitic and stearic acids on sucrose motivation and hypothalamic and striatal cell signals in the rat.

Figlewicz DP, Jay J, West CH, Zavosh A, Hampe CS, Radtke JR, Raskind MA, Peskind ER.

Am J Physiol Regul Integr Comp Physiol. 2018 Feb 1;314(2):R191-R200. doi: 10.1152/ajpregu.00340.2017. Epub 2017 Nov 1.

15.

Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.

Hampe CS, Roth CL.

Endocrine. 2017 Nov;58(2):207-227. doi: 10.1007/s12020-017-1433-z. Epub 2017 Oct 19. Review.

PMID:
29052181
16.

Immune-mediated cerebellar ataxias: from bench to bedside.

Mitoma H, Manto M, Hampe CS.

Cerebellum Ataxias. 2017 Sep 21;4:16. doi: 10.1186/s40673-017-0073-7. eCollection 2017. Review.

17.

Associations between Liver Enzyme Levels and Parameters of the Metabolic Syndrome in Obese Children.

Hampe CS, Shaffer ML, Roth CL.

Horm Res Paediatr. 2017;88(3-4):265-273. doi: 10.1159/000479868. Epub 2017 Sep 12.

PMID:
28898874
18.

Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias.

Mitoma H, Manto M, Hampe CS.

J Immunol Res. 2017;2017:2913297. doi: 10.1155/2017/2913297. Epub 2017 Mar 12. Review.

19.

A method for high-throughput functional imaging of single cells within heterogeneous cell preparations.

Neal AS, Rountree AM, Radtke JR, Yin J, Schwartz MW, Hampe CS, Posner JD, Cirulli V, Sweet IR.

Sci Rep. 2016 Dec 16;6:39319. doi: 10.1038/srep39319.

20.

Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Ganelin-Cohen E, Modan-Moses D, Hemi R, Kanety H, Ben-Zeev B, Hampe CS.

Pediatr Diabetes. 2016 Dec;17(8):617-622. doi: 10.1111/pedi.12346. Epub 2015 Dec 29.

21.

Neuronal central nervous system syndromes probably mediated by autoantibodies.

Chefdeville A, Honnorat J, Hampe CS, Desestret V.

Eur J Neurosci. 2016 Jun;43(12):1535-52. doi: 10.1111/ejn.13212. Epub 2016 Mar 28. Review.

22.

DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.

Bansal N, Hampe CS, Rodriguez L, O'Brian Smith E, Kushner J, Balasubramanyam A, Redondo MJ.

Diabet Med. 2017 May;34(5):641-646. doi: 10.1111/dme.13077. Epub 2016 Feb 12.

23.

Placental Barrier and Autism Spectrum Disorders: The Role of Prolactin and Dopamine on the Developing Fetal Brain.

Yarlagadda A, Acharya G, Kasaraneni J, Hampe CS, Clayton AH.

Innov Clin Neurosci. 2015 Sep-Oct;12(9-10):14-7. Review.

24.

Development of an Enhanced Sensitivity Bead-Based Immunoassay for Real-Time In Vivo Detection of Pancreatic β-Cell Death.

Costa OR, Stangé G, Verhaeghen K, Brackeva B, Nonneman E, Hampe CS, Ling Z, Pipeleers D, Gorus FK, Martens GA.

Endocrinology. 2015 Dec;156(12):4755-60. doi: 10.1210/en.2015-1636. Epub 2015 Oct 2.

25.

Prevalence and Regional Distribution of Autoantibodies Against GAD65Ab in a European Population Without Diabetes: The EPIC-InterAct Study.

Rolandsson O, Hampe CS, Wennberg P, Radtke J, Langenberg C, Wareham N; EPIC-InterAct Study Group.

Diabetes Care. 2015 Aug;38(8):e114-5. doi: 10.2337/dc15-0305. No abstract available.

26.

Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome.

Gu Urban GJ, Friedman M, Ren P, Törn C, Fex M, Hampe CS, Lernmark Å, Landegren U, Kamali-Moghaddam M.

Sci Rep. 2015 Jun 16;5:11196. doi: 10.1038/srep11196.

27.

Factors associated with early relapse to insulin dependence in unprovoked A-β+ ketosis-prone diabetes.

Gaba R, Gambhire D, Uy N, Gonzalez EV, Iyer D, Hampe CS, Ram N, Balasubramanyam A.

J Diabetes Complications. 2015 Sep-Oct;29(7):918-22. doi: 10.1016/j.jdiacomp.2015.04.013. Epub 2015 Apr 30.

28.

The urgent need to prevent type 1 autoimmune childhood diabetes.

Laron Z, Hampe CS, Shulman LM.

Pediatr Endocrinol Rev. 2015 Mar;12(3):266-82. Review.

PMID:
25962204
29.

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions.

Manto M, Honnorat J, Hampe CS, Guerra-Narbona R, López-Ramos JC, Delgado-García JM, Saitow F, Suzuki H, Yanagawa Y, Mizusawa H, Mitoma H.

Front Behav Neurosci. 2015 Mar 27;9:78. doi: 10.3389/fnbeh.2015.00078. eCollection 2015.

30.

Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, Honnorat J, Joubert B, Kakei S, Lee J, Manto M, Matsunaga A, Mizusawa H, Nanri K, Shanmugarajah P, Yoneda M, Yuki N.

Cerebellum. 2016 Apr;15(2):213-32. doi: 10.1007/s12311-015-0664-x. Review.

31.

Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.

Ling Z, De Pauw P, Jacobs-Tulleneers-Thevissen D, Mao R, Gillard P, Hampe CS, Martens GA, In't Veld P, Lernmark Å, Keymeulen B, Gorus F, Pipeleers D.

J Clin Endocrinol Metab. 2015 Jun;100(6):2314-21. doi: 10.1210/jc.2015-1216. Epub 2015 Mar 27.

32.

Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes.

Redondo MJ, Muniz J, Rodriguez LM, Iyer D, Vaziri-Sani F, Haymond MW, Hampe CS, Metzker ML, Grant SF, Balasubramanyam A.

BMJ Open Diabetes Res Care. 2014 Apr 6;2(1):e000008. doi: 10.1136/bmjdrc-2013-000008. eCollection 2014.

33.

Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes.

Redondo MJ, Rodriguez LM, Haymond MW, Hampe CS, Smith EO, Balasubramanyam A, Devaraj S.

Pediatr Diabetes. 2014 Dec;15(8):543-9. doi: 10.1111/pedi.12159. Epub 2014 Jun 30.

34.

Control of insulin secretion by cytochrome C and calcium signaling in islets with impaired metabolism.

Rountree AM, Neal AS, Lisowski M, Rizzo N, Radtke J, White S, Luciani DS, Kim F, Hampe CS, Sweet IR.

J Biol Chem. 2014 Jul 4;289(27):19110-9. doi: 10.1074/jbc.M114.556050. Epub 2014 May 19.

35.

Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.

Oak S, Gaur LK, Radtke J, Patel R, Iyer D, Ram N, Gaba R, Balasubramanyam A, Hampe CS.

J Clin Endocrinol Metab. 2014 Jun;99(6):E1040-4. doi: 10.1210/jc.2013-4189. Epub 2014 Mar 6.

36.

Antibodies to islet cell autoantigens, rotaviruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010-2011 winter viral seasons in Israel: a pilot study.

Shulman LM, Hampe CS, Ben-Haroush A, Perepliotchikov Y, Vaziri-Sani F, Israel S, Miller K, Bin H, Kaplan B, Laron Z.

Diabet Med. 2014 Jun;31(6):681-5. doi: 10.1111/dme.12404. Epub 2014 Feb 25.

37.

Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.

Brooks-Worrell BM, Iyer D, Coraza I, Hampe CS, Nalini R, Ozer K, Narla R, Palmer JP, Balasubramanyam A.

Diabetes Care. 2013 Dec;36(12):4098-103. doi: 10.2337/dc12-2328. Epub 2013 Oct 15.

38.

O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.

Kanwal S, Fardini Y, Pagesy P, N'tumba-Byn T, Pierre-Eugène C, Masson E, Hampe C, Issad T.

PLoS One. 2013 Jul 11;8(7):e69150. doi: 10.1371/journal.pone.0069150. Print 2013.

39.

Decline in titers of anti-idiotypic antibodies specific to autoantibodies to GAD65 (GAD65Ab) precedes development of GAD65Ab and type 1 diabetes.

Larsson HE, Jönsson I, Lernmark A, Ivarsson S, Radtke JR, Hampe CS; Diabetes Prediction in Skåne (DiPiS); Type 1 Diabetes Trial Network.

PLoS One. 2013 Jun 13;8(6):e65173. doi: 10.1371/journal.pone.0065173. Print 2013.

40.

Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats.

Hampe CS, Petrosini L, De Bartolo P, Caporali P, Cutuli D, Laricchiuta D, Foti F, Radtke JR, Vidova V, Honnorat J, Manto M.

Orphanet J Rare Dis. 2013 Jun 5;8:82. doi: 10.1186/1750-1172-8-82.

41.

Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease.

Hargreaves CE, Grasso M, Hampe CS, Stenkova A, Atkinson S, Joshua GW, Wren BW, Buckle AM, Dunn-Walters D, Banga JP.

J Immunol. 2013 Jun 1;190(11):5373-81. doi: 10.4049/jimmunol.1203412. Epub 2013 Apr 29.

42.

Characteristics of patients with ketosis-prone diabetes (KPD) presenting with acute pancreatitis: implications for the natural history and etiology of a KPD subgroup.

Fernandez R, Misra R, Nalini R, Hampe CS, Ozer K, Balasubramanyam A.

Endocr Pract. 2013 Mar-Apr;19(2):243-51. doi: 10.4158/EP12287.OR.

PMID:
23529349
43.

High titers of autoantibodies to glutamate decarboxylase in type 1 diabetes patients: epitope analysis and inhibition of enzyme activity.

Hampe CS, Maitland ME, Gilliam LK, Phan TH, Sweet IR, Radtke JR, Bota V, Ransom BR, Hirsch IB.

Endocr Pract. 2013 Jul-Aug;19(4):663-8. doi: 10.4158/EP12318.OR.

44.

The GABAergic septohippocampal pathway is directly involved in internal processes related to operant reward learning.

Vega-Flores G, Rubio SE, Jurado-Parras MT, Gómez-Climent MÁ, Hampe CS, Manto M, Soriano E, Pascual M, Gruart A, Delgado-García JM.

Cereb Cortex. 2014 Aug;24(8):2093-107. doi: 10.1093/cercor/bht060. Epub 2013 Mar 10.

45.

Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals.

Chéramy M, Hampe CS, Ludvigsson J, Casas R.

Clin Exp Immunol. 2013 Mar;171(3):247-54. doi: 10.1111/cei.12026.

46.

Pathogenesis of A⁻β⁺ ketosis-prone diabetes.

Patel SG, Hsu JW, Jahoor F, Coraza I, Bain JR, Stevens RD, Iyer D, Nalini R, Ozer K, Hampe CS, Newgard CB, Balasubramanyam A.

Diabetes. 2013 Mar;62(3):912-22. doi: 10.2337/db12-0624. Epub 2012 Nov 16.

47.

Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2.

Pierre-Eugene C, Pagesy P, Nguyen TT, Neuillé M, Tschank G, Tennagels N, Hampe C, Issad T.

PLoS One. 2012;7(7):e41992. doi: 10.1371/journal.pone.0041992. Epub 2012 Jul 26.

48.

Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.

Wang X, Zhang A, Liu Y, Chen S, Feng Z, Shang W, Maziarz M, Radtke J, Hampe CS.

PLoS One. 2012;7(2):e32515. doi: 10.1371/journal.pone.0032515. Epub 2012 Feb 24.

49.

Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.

Hampe CS.

Autoimmunity. 2012 Jun;45(4):320-31. doi: 10.3109/08916934.2012.659299. Epub 2012 Feb 23. Review.

50.

B Cell in Autoimmune Diseases.

Hampe CS.

Scientifica (Cairo). 2012;2012. pii: 215308.

Supplemental Content

Support Center